- Home
- TLSI vs INGN Comparison
TLSI vs INGN Comparison
Compare TLSI & INGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSI
- INGN
- Stock Information
- Founded
- TLSI 2010
- INGN 2001
- Country
- TLSI United States
- INGN United States
- Employees
- TLSI N/A
- INGN N/A
- Industry
- TLSI Medical Specialities
- INGN Industrial Specialties
- Sector
- TLSI Health Care
- INGN Health Care
- Exchange
- TLSI Nasdaq
- INGN Nasdaq
- Market Cap
- TLSI 244.3M
- INGN 219.3M
- IPO Year
- TLSI N/A
- INGN 2014
- Fundamental
- Price
- TLSI $4.73
- INGN $8.62
- Analyst Decision
- TLSI Strong Buy
- INGN Strong Buy
- Analyst Count
- TLSI 4
- INGN 3
- Target Price
- TLSI $11.13
- INGN $11.00
- AVG Volume (30 Days)
- TLSI 118.6K
- INGN 189.8K
- Earning Date
- TLSI 11-13-2025
- INGN 11-06-2025
- Dividend Yield
- TLSI N/A
- INGN N/A
- EPS Growth
- TLSI N/A
- INGN N/A
- EPS
- TLSI N/A
- INGN N/A
- Revenue
- TLSI $35,990,000.00
- INGN $343,472,000.00
- Revenue This Year
- TLSI $56.79
- INGN $7.93
- Revenue Next Year
- TLSI $54.15
- INGN $8.18
- P/E Ratio
- TLSI N/A
- INGN N/A
- Revenue Growth
- TLSI 45.50
- INGN 5.15
- 52 Week Low
- TLSI $3.42
- INGN $5.70
- 52 Week High
- TLSI $5.88
- INGN $12.91
- Technical
- Relative Strength Index (RSI)
- TLSI 48.36
- INGN 60.26
- Support Level
- TLSI $4.42
- INGN $8.06
- Resistance Level
- TLSI $4.67
- INGN $8.78
- Average True Range (ATR)
- TLSI 0.23
- INGN 0.34
- MACD
- TLSI -0.03
- INGN -0.03
- Stochastic Oscillator
- TLSI 61.87
- INGN 70.81
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About INGN Inogen Inc
Inogen Inc is a medical technology company that develops and manufactures portable oxygen concentrators used to deliver oxygen therapy to patients with chronic respiratory conditions. Its key product, the Inogen One system, is a lightweight alternative to traditional, stationary oxygen concentrator systems and oxygen tanks. The firm sells its products to home medical equipment providers and also rents products directly to patients. Internationally, It sells its products through distributors large gas companies, and home oxygen providers. It generates the majority of its revenue in the United States.